Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail
-

Current Drug Shortages A - D

 

The information provided in this section is provided voluntarily by manufacturers.  FDA cannot require firms to report the reason for shortage or duration of the shortage or any other information about shortages.  FDA appreciates all information provided by manufacturers.  We post information about shortages as soon as we receive it from the manufacturers.  To report information about shortages or supply issues, manufacturers can send updates to drugshortages@fda.hhs.gov.  Healthcare professionals and patients are also encouraged to notify us of shortages at drugshortages@fda.hhs.gov.

*Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012

[A – D]  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Acetylcysteine Inhalation Solution

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Hospira Inc. Customer Service:
1-877-946-7747		 100 mg/mL; 30 mL vial
(NDC 0409-3307-03)

Next delivery December

Estimated recovery: 1Q 2013

Please check with your wholesaler for available inventory.

 Demand increase for the drug.

Revised 10/12/2012
200 mg/mL; 30 mL vial
(NDC 0409-3308-03)

Next delivery December

Estimated recovery: 1Q 2013
Roxane Laboratories
1-614-276-4000

 		 200 mg/mL, 10 mL (NDC 00054-3028-02)  

Roxane Laboratories has all acetylcysteine inhalation solution presentations on backorder and the company cannot provide an anticipate release date.

Shortage per Manufacturer: Manufacturing Delay
 

 Demand increase for the drug.  
200 mg/mL, 30 mL (NDC 00054-3026-02)
American Regent/Luitpold
631-924-4000		 100 mg/mL, 4 mL (NDC 00517-7504-25) Unavailable

American Regent is currently not releasing Acetylcysteine inhalation solution.

  Other Revised 10/17/2012
100 mg/mL, 10 mL (NDC 00517-7510-03)
200 mg/mL, 4 mL (NDC 00517-7604-25)
200 mg/mL, 10 mL (NDC 00517-7610-03)
200 mg/mL, 30 mL (NDC 00517-7630-03)

 

Alfentanil Injection (Initial Posting Date) - 1/23/2012

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Akorn Pharmaceuticals
1-800-932-5676		 0.5 mg/ml; 2ml ampule (NDC 17478-0067-02) Readily available

Shortage per Manufacturer:
Quota request filed
Partial DEA authorization
 

  Other Revised 9/25/2012
0.5 mg/ml; 5ml ampule (NDC 17478-0067-05) On backorder due to release late October
Hospira, Inc. Customer Service:
1-877-946-7747		 500 mcg/mL; 2 mL amp (NDC 0409-2266-02) Available

Please check your wholesaler for all available inventory.

 

Due to increased demand, could see intermittent supply issues over the next couple months, until stable inventory position is attained.


 

 Demand increase for the drug.

Reverified 10/12/2012
500 mcg/mL; 5 mL amp (NDC 0409-2266-05) Available

 

Amikacin Injection

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Teva Pharmaceuticals
1-800-545-8800


 
250 mg/mL 4 mL vials   (NDC 00703-9040-03)
Teva has 4mL vials available for drop shipment only through the month of September.
Teva expects to continue to allocate the product for the remainder of 2012. 
 Demand increase for the drug.
Revised
10/18/2012
Bedford Customer Service
1-800-562-4797



 
250 mg/mL, 2 mL vials (NDC 55390-0226-02)
Unavailable
Bedford Laboratories has 500mg/2ml and 1gm/4ml available in limited quantities.  Once this supply is depleted, the next estimated release dates are unknown. Availability of products is updated on the Bedford  Laboratories website.
Shortage per Manufacturer:
Manufacturing delays
 Discontinuation of the manufacture of the drug.
Revised-
4/10/2012
250 mg/mL, 4 mL vials (NDC 55390-0226-04)

 

Amino Acid Products (Initial Posting Date) - 2/14/2012

For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Parenteral and Enteral Nutrition:
http://www.nutritioncare.org/Professional_Resources/Information_to_Use_in_the_Event_of_an_Intravenous_Amino_Acids_Shortage/

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Hospira, Inc.
Customer Service:
1-877-946-7747		 Aminosyn II 10%, Sulfite-free; 1 L bag (NDC 0409-4164-05)

Temporarily suspended

 

Please check with your wholesaler for available inventory.

 Other, Requirements related to complying with good manufacturing practices, and Discontinuation of the manufacture of the drug. Revised 10/12/2012
Aminosyn 10%, Sulfite-free; 500 mL bag (NDC 0409-4191-03) Available
Aminosyn 8.5%, Sulfite-free; 500 mL bag (NDC 0409-4187-03) Available
Temporarily suspended
Aminosyn II 15%, Sulfite-free; 2 L bag (NDC 0409-7171-17)
Aminosyn II 10%, Sulfite-free; 2 L bag (NDC 0409-7172-17) Available
Aminosyn 10%, Sulfite-free, 1 L (NDC 0409-4191-05) Temporarily suspended
Aminosyn II 10%, 500 mL, Sulfite-free (NDC 0409-4164-03) Available
Aminosyn HBC 7%, 500 mL, Sulfite-free (NDC 0409-4168-03) Temporarily suspended
Aminosyn 3.5%, sulfite-free, 1 L (NDC 0409-4196-05) Available
Aminosyn II 8.5%, sulfite-free, 500 mL (NDC 0409-4162-03) Available
Aminosyn II 8.5% with electrolytes, sulfite-free, 500 mL (NDC 0409-4171-03)
Available
Aminosyn-PF 7%, sulfite-free, 500 mL (NDC 0409-4178-03) Available
Aminosyn-PF 10%, 1000 mL, sulfite-free (NDC 0409-4179-05) Available
Aminosyn RF 5.2%, 500 mL, sulfite-free (NDC 0409-4166-03) Temporarily suspended
Aminosyn II 10%; 2 L bag (NDC 0409-7121-07) Product being replaced by (NDC 0409-7172-17)
B. Braun Medical Inc.
Customer Service:
1-800-227-2862		 TrophAmine 6%, 500 mL (NDC 00264-9361-55) All presentations available

 

 

   Revised 10/17/2012
TrophAmine 10%, 500 mL (NDC 00264-9361-55)
FreAmine III 10%, 1000 mL (NDC 00264-9010-55)
Specialty Amino Acid Solutions FreAmine HBC 6.9%, 750 mL (NDC 00264-9350-55)
NephrAmine 5.4%, 250 mL (NDC 00264-1909-55)
HepatAmine 8%, 500 mL (NDC 00264-9371-55)
15% Amino Acids Injection 1,000 mL (NDC 0264-3200-55)

Baxter Customer Service:
1-800-262-3784

 

 Travasol 10%, 500 mL (NDC 00338-0644-03)

Baxter is currently experiencing a backorder situation on all presentations of Prosol, Premasol and Clinisol due to unforeseen demand. Allocated availability continued through November 2012.

 

Clinimix is a viable source of Amino Acids for most patients requiring parenteral nutrition.

 

 Demand increase for the drug

Revised 9/24/2012
Travasol 10%, 1000 mL (NDC 00338-0644-04)
Travasol 10%, 2000 mL (NDC 00338-0644-06)
Prosol 20%, 2000 mL, sulfite-free (NDC 00338-0499-06)
Clinisol 15%, 500 mL, sulfite-free (NDC 00338-0502-03)
Clinisol 15%, 2000 mL, sulfite-free (NDC 00338-0502-06)
Premasol 6%, 500 mL, sulfite-free (NDC 00338-1131-03)
Premasol 10%, 500 mL, sulfite-free (NDC 00338-1130-03)
Premasol 10%, 1000 mL, sulfite-free (NDC 00338-1130-04)
Premasol 10%, 2000 mL, sulfite-free (NDC 00338-1130-06)
Hepatosol 8%, 500 mL (NDC 00338-0504-03)
CLINIMIX sulfite-free (2.75%, 4.25%, 5.0% Amino Acid in Dextrose) Injections in 1000 mL and 2000 mL Containers
CLINIMIX E sulfite-free (2.75%, 4.25%, 5.0% Amino Acid with Electrolytes in Dextrose with Calcium) Injections in 1000 mL and 2000 mL Containers

 

Ammonium Chloride Injection

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated

Hospira, Inc.  Customer Service:
1-877-946-7747

 5 mEq/mL; 20 mL vial

(NDC 0409-6043-01)

 

Company estimates a release date by 1Q 2013

Estimated recovery: 2Q 2013

Please check with your wholesaler for available inventory.

Shortage per Manufacturer: Manufacturing delay

 Other Reverified 10/12/2012

 

Ammonul (sodium phenylacetate and sodium benzoate) Injection 10%/10% (9/18/2008)

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated

Ucyclyd Pharma, Inc. 1-888-829-2593, or 1-800-900-6389 with a representative available 24 hours, seven days a week.
phone

 50mL vial (NDC 62592-720-50) Limited supplies continue to be available.

Please see attached Dear Healthcare Professional Letter (PDF - 25KB) for important safety information.

  Other Revised 4/26/2012

 

Amphetamine Mixed Salts, ER Capsules  (updated 10/31/2011)

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Shire Customer Service:
1-800-828-2088

Adderall XR capsules		 5 mg - 100 count (NDC 54092-0381-01) Product availability for all dosage strengths is adequate. Shortage per Manufacturer:
API supply issues and uneven product distribution patterns.		 Demand increase for the drug  
10 mg - 100 count (NDC 54092-0383-01)
15 mg - 100 count (NDC 54092-0385-01)
20 mg - 100 count (NDC 54092-0387-01)
25 mg - 100 count (NDC 54092-0389-01)
30 mg - 100 count (NDC 54092-0391-01)
Teva Customer Service
(888)838-2872		 5 mg - 100 count (NDC 00555-0790-02) Teva continues to release product as it becomes available.   Shortage of active ingredient. Reverified
10/18/2012
10 mg - 100 count (NDC 00555-0787-02) Teva continues to release product as it becomes available.
15 mg - 100 count (NDC 00555-0791-02) Teva continues to release product as it becomes available.
20 mg - 100 count (NDC 00555-0788-02) Teva continues to release product as it becomes available.
25 mg - 100 count (NDC 00555-0792-02) Teva continues to release product as it becomes available.
30 mg - 100 count (NDC 00555-0789-02) Teva continues to release product as it becomes available.
Global Customer Service:
(215)558-4300		 10 mg ,100 count (NDC 00115-1329-01) All finished product strengths are currently available on an allocated basis. Shortage per Manufacturer:
Inadequate finished product supply to support current market demand		 Demand increase for the drug  
15 mg, 100 count (NDC 00115-1330-01)
20 mg, 100 count (NDC 00115-1331-01)
25 mg, 100 count (NDC 00115-1332-01)
30 mg, 100 count (NDC 00115-1333-01)

 

Amphetamine Mixed Salts Immediate-Release Tablets (updated 1/12/2012)

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Sandoz Customer Service:
1-609-627-8500		 5 mg tablets, 100 count (NDC 00185-0084-01) All strengths are available.   Demand increase for the drug Reverified 10/1/2012
10 mg tablets, 100 count (NDC 00185-0111-01)
20 mg tablets, 100 count (NDC 00185-0401-01)
30 mg tablets, 100 count (NDC 00185-0404-01)
CorePharma
1-800-850-2719		 5 mg tablets, 100 count (NDC 64720-0130-10) CorePharma is releasing product as it becomes available. Shortage per Manufacturer:
Increase in demand		 Demand increase for the drug  
10 mg tablets, 100 count (NDC 64720-0132-10)
20 mg tablets, 100 count (NDC 64720-0135-10)
30 mg tablets, 100 count (NDC 64720-0136-10)
Teva Customer Service:
1-888-838-2872		 5 mg tablets, 100 count (NDC 00555-0971-02) Teva supply is adequate to meet demand.   Shortage an active ingredient Revised 10/18/2012
7.5 mg tablets, 100 count (NDC 00555-0775-02) Teva supply is adequate to meet demand.
10 mg tablets, 100 count (NDC 00555-0972-02) Low inventory, possible backorders through November 
12.5 mg tablets, 100 count (NDC 00555-0776-02) Teva supply is adequate to meet demand.
15 mg tablets, 100 count (NDC 00555-0777-02) Teva supply is adequate to meet demand.
20 mg tablets, 100 count (NDC 00555-0973-02) Low inventory, possible backorders through November 
30 mg tablets, 100 count (NDC 00555-0974-02) Low inventory, possible backorders through November
Adderall, 5 mg tablets, 100 count (NDC 00555-0762-02) Teva supply is adequate to meet demand.
Adderall, 7.5 mg tablets, 100 count (NDC 00555-0763-02)
Adderall, 10 mg tablets, 100 count (NDC 00555-0764-02)
Adderall, 12.5 mg tablets, 100 count (NDC 00555-0765-02)
Adderall, 15 mg tablets, 100 count (NDC 00555-0766-02)
Adderall, 20 mg tablets, 100 count (NDC 00555-0767-02)
Adderall, 30 mg tablets, 100 count (NDC 00555-0768-02)

 

Aquasol A

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Hospira Inc.
1-877-946-7747		 50,000 units/mL, 2 mL ampule (NDC 61703-418-07) Next delivery TBD Shortage per Manufacturer: Change in manufacturing site Other Reverified 9/24/2012

 

Atracurium besylate (updated 2/27/2012)

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Bedford Customer Service: 1-800-562-4797 10 mg/mL, 5 mL vial, single dose vial (NDC 55390-0102-05)  

Bedford Laboratories has 50mg Inj SDV 5ml and 100mg Inj MDV 10ml available in limited quantities.  Once this supply is depleted, the next estimated release dates are unknown. Availability of products is updated on the Bedford  Laboratories website.

Shortage per Manufacturer:
Manufacturing delays

 Discontinuation of the manufacture of the drug. Revised 4/10/2012
10 mL vial, multi-dose vial (NDC 55390-0103-10)
5 mL Novaplus vial, single dose vial (NDC 55390-0180-05)
10 mL Novaplus vial, multi-dose vial (NDC 55390-0179-10)
Sagent Pharmaceticals
1-866-625-1618		 10 mg/mL, 5 mL single dose vial, (NDC 25021-659-05) On allocation Products launched end of May, 2012. Demand increase for the drug.  Reverified 10/22/2012
10 mg/mL, 10 mL multi-dose vial (NDC 25021-672-10) On allocation

 

Atropine Sulfate Injection

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Amphastar Pharmaceuticals Inc.
Customer Service:
1-800-423-4136

0.1 mg/mL, 10 mL, Luer-Jet Prefilled Syringe

 

NDC 76329-3339-1

(old NDC 00548-3339-00) 

 Amphastar will regularly release products. Shortage per Manufacturer: Increase in product demand caused by market supply issues.  Demand increase for the drug Revised 9/24/2012
Hospira, Inc.
Customer Service:
1-877-946-7747		  0.1 mg/mL; 10 mL Ansyr syringe
(NDC 0409-1630-10)		 Available

Please check with your wholesaler for available inventory. 

Shortage per Manufacturer:
Manufacturing delay
 

 Other

Reverified 10/12/2012
0.05 mg/mL; 5 mL Ansyr syringe
(NDC 0409-9630-05)		 Next delivery and estimated recovery 1Q 2013
0.1 mg/mL; 5 mL Lifeshield syringe
(NDC 0409-4910-34)		 Next delivery and estimated recovery 1Q 2013
0.1 mg/mL; 10 mL Lifeshield syringe
(NDC 0409-4911-34)		 Next delivery and estimated recovery 1Q 2013
American Regent/Luitpold
1-800-645-1706		 0.4 mg/mL, 0.5 mL ampule, package of 25
(NDC 00517-0805-25)		 Unavailable

Shortage per Manufacturer:
American Regent/Luitpold has discontinued manufacturing the ampoules  

 Discontinuation of the manufacture of the drug. Reverified 10/17/2012
0.4 mg/mL, 1 mL single-dose vial, package of 25
(NDC 00517-0401-25)		 Unavailable Shortage per Manufacturer:
American Regent is currently not releasing Atropine Sulfate Injection 0.4 mg/mL, 1 mL single-dose vial
1 mg/mL, 1 mL single-dose vial, package of 25
(NDC 00517-1010-25)		 Unavailable Please check with your wholesaler for available inventory.
1 mg/mL, 1 mL ampule, package of 25 (NDC 00517-0101-25) Unavailable Shortage per Manufacturer:
American Regent/Luitpold has discontinued manufacturing the ampoules
West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174
(Formerly a Baxter Product)

0.4 mg/mL, 20 mL vial
(NDC 0641-6006-10)

West-Ward currently has limited quantities available.

 

Additional lots will also be manufactured and available in August 2012.

 

Product will be made available as it is released.

Shortage per Manufacturer:
Increase in product demand.

 Demand increase for the drug. Revised
7/9/2012

 

Bacteriostatic 0.9% Sodium Chloride (Initial posting-9/10/2012)

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Hospira Inc.
Customer Service:
1-877-946-7747		 20 mL vial
(NDC 0409-1966-05)
 

Next delivery December Estimated recovery: December
 

Please check with your wholesaler for available inventory.
Shortage per Manufacturer: manufacturing delay
 

 Other Revised 10/12/2012
30 mL vial
(NDC 0409-1966-07)
 

Next delivery October Estimated recovery: 1Q 2013
 
10 mL vial
(NDC 0409-1966-12)
 

Next delivery December Estimated recovery: 4Q 2013
 
APP
1-888-386-1300		 30 mL MD Vial Glass
(NDC # 63323-259-30) 

Next delivery for October 2012 

Shortage per Manufacturer:
Increased demand 

 Demand increase for the drug Revised 10/19/2012
30 mL MD Vial Plastic
(NDC # 63323-924-30) 		 Available
Check wholesaler inventory 
10mL MD Vial Plastic
(NDC # 63323-924-10) 		 Next delivery for October 2012
 

 

Barium Sulfate for Suspension (Initial posting-10/12/2012)

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated

E-Z-EM Inc.
Customer Service:
1-800-631-5245

 E-Z-HD BARIUM SULFATE FOR SUSPENSION (98% w/w),(NDC 32909-764-01)

 


 


 



 
 

 


 		 Shortage of an active ingredient.



 
 
DIGIBAR 190 BARIUM SULFATE FOR SUSPENSION, (190% w/v when constituted 232 g), (NDC 32909-270-19 )
 		 Demand increase for the drug
MAXIBAR BARIUM SULFATE SUSPENSION (210% w/v, 80% w/w),(NDC 32909-150-08) Demand increase for the drug
LIQUID E-Z-PAQUE BARIUM SULFATE SUSPENSION (60% w/v, 41% w/w),(NDC 32909-186-02) Shortage of an active ingredient.
 
LIQUID E-Z-PAQUE BARIUM SULFATE SUSPENSION (60% w/v, 41% w/w),(NDC 32909-186-01) Shortage of an active ingredient.
 
LIQUID POLIBAR PLUS BARIUM SULFATE SUSPENSION (105% w/v, 58% w/w), (NDC 32909-168-02) Demand increase for the drug
POLIBAR ACB BARIUM SULFATE (96% w/w),  (NDC 32909-804-01) Shortage of an active ingredient.
 
POLIBAR ACB BARIUM SULFATE (96% w/w), NDC 32909-804-02 Shortage of an active ingredient.
 
E-Z-CAT DRY BARIUM SULFATE FOR SUSPENSION (2% w/w After Mixing), (NDC 32909-727-01) Shortage of an active ingredient.
 
E-Z-DISK BARIUM SULFATE TABLETS (NDC 10361-778-31) Demand increase for the drug

 

Boniva (ibandronate sodium) Injection (Initial posting-6/6/2012)

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Genentech, Inc.
Customer Service:
1-800-551-2231		 3 mg/mL (single use syringe)
Box of 1 (NDC 0004-0191-09

Current backlog at the US distribution center expected to continue until end-October 2012.

Please check with your wholesaler for available inventory.
 

Shortage per Manufacturer:
Compliance issue with i.v. infusion set that is enclosed in product kit and supplied by a third-party vendor

 Other Revised 10/3/2012

 

Bumetanide Injection (Initial posting-6/21/12)

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Hospira Inc. Customer Service:
1-877-946-7747		 0.25mg/mL; 4mL
(NDC 00409-1412-04)		 Available

Drug product allocated to direct orders 

Demand increase for the drug.

 Revised 10/12/2012
0.25mg/mL; 10mL vial
(NDC 00074-1412-10)

Next delivery October Estimated recovery: December
West-Ward Pharmaceuticals
Customer Service:
1-800-631-2174		 Bumetanide Injection, USP
(formerly a Baxter product)

0.25 mg/mL, 10 mL vial
(NDC 0641-6007-10)		 West-Ward has very limited quantities available for both presentations.

Additional lots of each code are scheduled for production and units are expected to be available in the beginning of August 2012.

Product will be made available as it is released.		 Shortage per Manufacturer:
Increase in product demand due to market supply issues.		 Demand increase for the drug. Revised 6/25/2012
0.25mg/mL, 4mL vial
(NDC 00641-6008-10)
Bedford
Customer Service:
1-800-562-4797		 0.25mg/mL, 2 mL vial (NDC 55390-0500-02) Not available Shortage per Manufacturer:
Manufacturing delay		 Discontinuation of the manufacture of the drug.  
0.25mg/mL, 4 mL vial (NDC 55390-0500-05)
0.25mg/mL, 10 mL vial (NDC 55390-0500-10)

 

Bupivacaine Hydrochloride Injection 

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
APP
1-888-386-1300		   APP has Sensorcaine (with & without Epinephrine) on intermittent back-order and the company is releasing product as it becomes available. Check Wholesaler Inventory. 

Shortage per Manufacturer:
Increased demand

 Demand increase for the drug. Reverified 10/3/2012

Hospira, Inc.
Customer Service
1-877-946-7747

 


 

 0.25%; 30 mL amp
(NDC 0409-1158-01) 		 Available

Please check with your wholesaler for available inventory. 
 

 

Shortage per Manufacturer: manufacturing delay

Other

Revised 10/23/2012
0.25%; 10 mL vial
(NDC 0409-1159-01)		 Next delivery October Estimated recovery: 4Q 2012
0.25%; 30 mL vial
(NDC 0409-1159-02)

Next delivery November Estimated recovery: December
0.25%; 50 mL vial
(NDC 0409-1160-01)		 Available
0.5%; 30 mL amp
(NDC 0409-1161-01)		 Next delivery October
Estimated recovery 4Q 2012
 
0.5%; 10 mL vial
(NDC 0409-1162-01)

Available
0.5%; 30 mL vial
(NDC 0409-1161-02)

Next delivery October

Estimated recovery: 4Q 2012 
0.5%; 30 mL vial
(NDC 0409-1162-02)		 Next delivery November
Estimated recovery: 2Q 2013
 
0.5%; 50 mL vial
(NDC 0409-1163-01)		 Available
0.75%; 10 mL vial
(NDC 0409-1165-01)

Next delivery October

Estimated recovery: 1Q 2013
0.75%; 30 mL vial
(NDC 0409-1165-02)

Next delivery November
Estimated recovery: 2Q 2013
0.75% in Dex 8.25%; 2mL amp (NDC 0409--3613-01)

Next delivery December
Estimated recovery: 1Q 2013
 
0.5% w/epi 1:200,000; Carpujects (NDC 0409-7600-01) Next delivery and estimated recovery 1Q 2013
0.25% w/epi 1:200,000; 10 mL vial
(NDC 0409-9042-01)

Next delivery October  Estimated recovery: 1Q 2013
0.25% w/epi 1:200,000; 30 mL vial(NDC 0409-9042-17)
 		 Available 
0.25% w/epi 1:200,000; 50 mL (NDC 0409-9043-01)

Next delivery October

Estimated recovery: 1Q 2013
 
0.5% w/epi 1:200,000; 10 mL (NDC 0409-9045-01)

Next delivery October
 

Estimated recovery: October 
0.5% w/epi 1:200,000; 30 mL (NDC 0409-9045-17)
 		 Available
 
0.5% w/epi 1:200,000; 50 mL (NDC 0409-9046-01)  Available
50 mg/20 mL Sterile pack amp (NDC 0409-4272-01)

Next delivery and recovery December 

100mg/20mL Sterile pack amp (NDC 0409-4273-01)		 Next delivery November Estimated recovery 4Q 2012

 

Buprenorphine Injection

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Bedford
1-800-562-4797		 1 mL vial (NDC 55390-0010-10)  

Bedford has buprenorphine injection on back order and the company cannot estimate a release date.

Shortage per Manufacturer:
Delays

 Discontinuation of the manufacture of the drug.  
Hospira
1-877-946-7747		 1 mL Carpuject syringe (NDC 0409-2012-32 Next delivery and estimated recover TBD  

Shortage of an active ingredient/Demand increase for the drug.

Revised 10/12/2012

 
American Regent/Luitpold
1-800-645-1706		 1 mL vial (NDC 00517-0725-05) Unavailable Shortage per Manufacturer:
Currently not releasing.		  Other Reverified 10/16/2012
Reckitt Benckiser
804-379-1090

Buprenex 0.3 mg/mL 1 mL ampules (NDC 12496-0757-01)		 Buprenex 0.3 mg/mL 1 mL ampules (NDC 12496-0757-01) are available  

Reckitt Benckiser has Buprenex 0.3 mg/mL 1 mL ampules (NDC 12496-0757-01) available.

 

  Other  

 

Butorphanol Injection

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated

Hospira, Inc.
Customer Service:
1-877-946-7747 

1 mg/mL; 1 mL vial

(NDC 0409-1623-01)

 

Next delivery October Estimated recovery: December

Please check with your wholesaler for all available inventory. 

 

 

 Demand increase for the drug

Revised 10/12/2012

2 mg/mL; 1 mL vial

(NDC 0409-1626-01)

 Available

2 mg/mL; 2 mL vial

(NDC 0409-1626-02)

Next delivery December Estimated recovery December
Bedford Customer Service:
1-800-562-4797		 1 mg/mL 1 mL vial (NDC 55390-0183-01) Bedford has all butorphanol presentations on back order and the company cannot estimate a release date.
 		 Shortage per Manufacturer:
Manufacturing delays		 Discontinuation of the manufacture of the drug.  
1 mg/mL 1 mL Novaplus vial (NDC 55390-0341-10)
2 mg/mL 1 mL vial (NDC 55390-0184-01)
2 mg/mL 2 mL vial (NDC 55390-0184-02)
2 mg/mL 1 mL Novaplus vial (NDC 55390-0342-10)
2 mg/mL 10 mL vial (NDC 55390-0185-10)

 

Caffeine, anhydrous (125 mg/mL) and Sodium benzoate (125 mg/mL)

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
American Regent/Luitpold:
631-924-4000		 2 mL single-dose vial, package of 10 (NDC 00517-2502-10) Unavailable Currently not releasing.  Other Reverified 10/17/2012

 

Caffeine and Ergotamine Tartrate Tablet (Initial Posting-3/8/2012)

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Sandoz Customer Service:
1-609-627-8500		 100 mg caffeine/ 1 mg ergotamine tartrate; 100 count bottle (NDC 00781-5405-01 Temporarily unavailable and Sandoz cannot estimate a release date.

Change in the raw material plant location, we will continue to provide updates as further information becomes available.

 Shortage of an active ingredient. Reverified 10/1/2012

 

Cardiolite, Kit for the Preparation of Technetium Tc99m Sestamibi for Injection (Initial Posting Date) – 5/4/2012

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Lantheus Medical Imaging
1-800-299-3431

5 vial kit (NDC 11994-001-55)

 		 Lantheus has limited supplies available and continue to release product as it becomes available. Shortage per Manufacturer:
Manufacturing delays at contract manufacturer and limited supply available from alternate contract manufacturer		 Requirements related to complying with good manufacturing practices Reverified 9/26/2012
20 vial kit (NDC 11994-001-20)

 

Cetrorelix Acetate for Injection (Initial Posting Date) – 9/20/2012

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
EMD Serono, Inc.
1-888-275-7376		 0.25 mg  (NDC 44087-1225-1) Product is currently available on an allocated basis.
 		   Demand increase for the drug.  

 

Chloroprocaine (Nesacaine) Injection (Initial Posting 3/28/2012)

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
APP

1-888-386-1300		 10 mg/mL with preservative, 30 mL vial, 25 count (NDC 63323-0475-37) Available

Shortage per Manufacturer:
Increased Demand

 Demand increase for the drug. Revised 10/18/2012
20 mg/mL with preservative, 30 mL vial, 25 count (NDC 63323-0476-37) Available
20mg/mL with preservative, 20 mL vial, 25 count (NDC 63323-0477-27) Next delivery for November 2012
30 mg/mL preservative-free, 20 mL vials, 25 count (NDC 63323-0478-27) Next delivery for November 2012
Bedford Laboratories 20 mg/mL preservative-free, 20 mL vials (NDC 55390-0403-20) Bedford Laboratories is out of stock and the company cannot estimate a release date.

Production is pending as capacity permits. Availability of products is updated on the Bedford Laboratories website disclaimer icon.

Shortage per Manufacturer:
Manufacturing delays

 Discontinuation of the manufacture of the drug 3/28/2012
30 mg/mL preservative-free, 20 mL vials (NDC 55390-0404-20)

 

Chromic Chloride Injection

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Hospira, Inc.
Customer Service
1-877-946-7747		 4 mcg/mL; 10 mL vial
(NDC 0409-4093-01)		 Next delivery and estimated recovery December

Shortage per Manufacturer:
 
Other manufacturer shortage/market withdrawal.

 Demand increase for the drug.

Reverified 10/12/2012
American Regent/Luitpold
1-800-645-1706		 SOL 4 mcg/ml INTRAVENOUS 10 ml 25s (NDC 00517-6310-25) Unavailable

Currently not releasing

 Other Reverified 10/17/2012

 

Citric Acid; Gluconolactone; Magnesium Carbonate Solution (Renacidin); Irrigation (Initial posting– 6/30/2012)

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated

United Guardian

Customer Service:
1-800-645-5566

Renacidin® Irrigation

6.602GM/100ML;198MG/100ML;3.177GM/100ML 
  
(NDC: 00327-00011-05)

Limited Availability

 Shortage per Manufacturer:
Manufacturing Delay		 Other  

 

Corticorelin Ovine Triflutate

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Ferring Pharmaceuticals, Inc.
1-888-Ferring
(1-888-337-7464)		 EQ 0.1 MG Base/Vial (NDC 55566-0302-1) No stock available

Shortage per Manufacturer:
Product availability pending resolution of compliance issues at manufacturing site

 Requirements related to complying with good manufacturing practices. Reverified 10/15/2012

 

Daunorubicin Hydrochloride Solution for Injection 

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Teva Pharmaceuticals
1-800-545-8800		 5 mg/mL, 4 mL single-dose vial (NDC 00703-5233-13) Teva has ample supply available     Revised 10/18/2012

Bedford Customer Service
1-800-562-4797 

 5 mg/mL, 4 mL single-dose vial (NDC 55390-0108-10) Available in limited quantities. Once this supply is depleted, the next estimated release dates are unknown.

Availability of products is updated on the Bedford Laboratories website

Shortage per Manufacturer:
Manufacturing delays

 Discontinuation of the manufacture of the drug.

Revised 

4/10/2012
10 mL single-dose vial (NDC 55390-0108-01)
Cerubidine lyophilized powder for injection, 20mg single-dose vial, package of 10 (NDC 55390-0281-10)

 

Desmopressin Injection

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated

Ferring
1 888 Ferring
(1-888-337-7464)

 

 

 4 mcg/mL 1ml vials (NDC 55566-5030-01)

Available

Shortage per Manufacturer: 
Available
 

  Other

Reverified 10/15/2012
4mcg/mL 10ml (NDC 55566-5040-01) Available
Hospira Inc. Customer Service:
1-877-946-7747		 4 mcg/mL, 1 mL amp (NDC 00409-2265-01)

Next delivery November Estimated recovery: December

Please check with your wholesaler for available inventory.

Demand increase for the drug. 

Revised 10/12/2012
Sanofi-Aventis
1-800-981-2491


 		 (DDAVP) 4 mcg/mL;  1 mL  ampule (NDC 00075-2451-01)  Both presentations available. Shortage per Manufacturer:
Available		  Other

Reverified 10/10/2012
4 mcg/mL; 10 mL vial (NDC 00075-2451-53)

Teva Pharmaceuticals
1-800-545-8800

   

 

  4mcg/mL, 4mcg (NDC 00703-5051-03)   All presentation on back order and the company cannot estimate a release date.   Requirements related to complying with good manufacturing practices Reverified 10/18/2012
4mcg/mL, 40 mcg (NDC 00703-5054-01)

 

Dexrazoxane Injection

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Mylan Institutional
1-888-258-4199		 250 mg vial (NDC 67457-0207-25)
 		 Available from wholesalers   Demand increase for the drug.
 

Reverified 10/10/2012
Pfizer Injectables
1-800-533-4535

http://www.pfizerinjectables.com/ disclaimer icon 		  Pfizer has product available for both strengths. Pfizer Injectables has available vials of 250 mg NDC (0013-8717-62), 500 mg (NDC 0013-8727-89).  Other

Reverified

6/25/2012

 
Topotarget USA, Inc.
1-973-895-6900		 Totect 500 mg (dexrazoxane) for injection
(NDC 38423-110-01)		  

Topotarget USA has worked with the US Food and Drug Administration (FDA) to increase the availability of Totect Kits.  Effective February 6, 2012, the FDA has approved the extension of the expiration date to 36 months for Totect Kits with following batch numbers:

Topotarget USA, Inc. has recently released additional 129 kits to help fill the back order for this product. The company cannot estimate a release for additional Totect Kits at this time.

Shortage per Manufacturer:
Manufacturing Delays

  Other Revised 4/26/2012

 

Dextroamphetamine Tablets (1/12/2012)

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Teva Pharmaceuticals
1-888-838-2872		 5 mg tablets, 100 count (NDC 00555-0952-02) Teva supply is adequate to meet demand.
 		  

Delay in shipping of the drug.

 Revised 10/18/2012
10 mg tablets, 100 count (NDC 00555-0953-02) Low inventory, possible backorders through November.
 

 

Dextrose Injection (Initial posting – 5/23/2012)

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Amphastar Pharmaceuticals, Inc.
Customer Service:
1-800-423-4136

50%, 50mL Luer-Jet Prefilled Syringe

 

NDC 76329-3301-1

(old NDC 0548-3301-00)		 Amphastar will regularly release products

Amphastar is  experiencing a product shortage due to an increase in product demand caused by market supply issues.

 

Shortage per Manufacturer:
Increased Demand

 Demand increase for the drug. Reverified 9/24/2012

 

Diazepam Injection

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Hospira, Inc.
Customer Service:
1-877-946-7747		 5 mg/mL; 2 mL Carpuject (0409-1273-32)

Next delivery October Estimated recovery: December

 Shortage per Manufacturer: manufacturing delay

Other 

Revised 10/12/2012
5 mg/mL; 10 mL vial
(0409-3213-12)

Next delivery October Estimated recovery: December

 

 Dipyridamole Injection (Initial posting-7/24/12)

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated

West-Ward Pharmaceuticals

Customer Service:
1-800-631-2174

Dipyridamole Injection, USP
(Formerly a Baxter Product)

5 mg/mL; 10 mL vial
(NDC 0641-2569-44)

 West-Ward is currently experiencing a backorder situation.
West-Ward has increased production and is anticipating having product available in the middle of August 2012.
Additional lots are projected to be available by the end of September 2012.
Product will be made available as it is released.		 Shortage per Manufacturer:
Increase in product demand due to market supply issues.		 Demand increase for the drug.

 

 

Doxorubicin (adriamycin) lyophilized powder (updated 12/2/2011)

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated
Bedford Laboratories Customer Service 1-800-562-4797 10 mg vials (NDC 55390-0231-01) Bedford Laboratories has 10 mg available in limited quantities. Once this supply is depleted, the next estimated release dates are unknown. Other presentations are pending release with release date yet to be determined.

Availability of products is updated on the Bedford Laboratories website.

Shortage per Manufacturer:
Manufacturing delays

 Discontinuation of the manufacture of the drug. Revised 4/10/2012
20 mg vials (NDC 55390-0232-10)
50 mg vials (NDC 55390-0233-01)

 

Doxorubicin Liposomal (Doxil) Injection

 

Company Product Availability and Estimated Shortage Duration Related Information Shortage Reason
(per New Legislation-FDASIA)*		 Date Updated

Janssen Products, LP

1-800-526-7736
(1-800-JANSSEN)

 Doxil 2 mg/mL, Janssen Products, LP
2 mg/mL, 10 mL (20 mg) vial (NDC 59676-0960-01)		 Limited supplies available.  A manufacturing supplement is under expedited review with FDA 

The DOXIL C.A.R.E.S. Physician Access Program has been suspended.  See consumer update at www.doxilsupply.com and healthcare professional update/DHCP letter at www.DOXIL.com.  A listing of JOM Pharmaceutical Services authorized distributors can be found at http://www.jom.com/products.html (select “DOXIL”)

 Other Revised 10/19/2012 
Sun Pharma Global FZE
(Caraco Pharmaceutical, U.S. distributor)
1-888-835-2237		 Lipodox (10 ml): NDC 47335-082-50 Available

Sun Pharma Global FZE, and its authorized distributor, Caraco Pharmaceutical Laboratories Ltd, in conjunction with the FDA, are initiating a temporary importation of Lipodox (doxorubicin HCL liposomal for injection), into the United States market to address this shortage. Please see the Dear Healthcare Professional Letter (PDF - 65KB) for information about supplies that are now available to help address the current shortage.

 

Frequently Asked Questions (FAQs) about Sun's Lipodox (doxorubicin HCL liposomal injection) (PDF - 20KB)

  Other Reverified 10/19/2012
Lipodox 50 (25 ml): NDC 47335-083-50

back to top of page

Current Drug Shortages Index

-
-